Economic Evaluation of Prostate Cancer Screening Test as a National Cancer Screening Program in South Korea |
Shin, Sangjin
(National Evidence-based Healthcare Collaborating Agency)
Kim, Youn Hee (National Evidence-based Healthcare Collaborating Agency) Hwang, Jin Sub (National Evidence-based Healthcare Collaborating Agency) Lee, Yoon Jae (National Evidence-based Healthcare Collaborating Agency) Lee, Sang Moo (National Evidence-based Healthcare Collaborating Agency) Ahn, Jeonghoon (National Evidence-based Healthcare Collaborating Agency) |
1 | Ministry for Health, Welfare, and Family Affairs (2005). The Third Korean National Health and Nutrition Examination Survey (KNHNES III) [Korean]. Seoul, Korea: Ministry for Health, Welfare, and Family Affairs. |
2 | Kim Y, Jun JW, Choi KS, et al (2011). Overview of the national cancer screening programme and the cancer screening status in Korea. Asian Pac J Cancer Prev, 12, 725-30. |
3 | Kobayashi T, Goto R, Fukui T, et al (2007). Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening. Int J Urol, 14, 805-10. DOI |
4 | Krahn MD, Mahoney JE, Eckman MH, et al (1994). Screening for prostate cancer. A decision analytic view. JAMA, 272, 773-80. DOI |
5 | National Health Insurance Corporation (2010). Survey of medical charges paid by patients with health insurance in 2009 [Korean]. Seoul, Korea: National Health Insurance Corporation. |
6 | Perez-Niddam K, Thoral F, Charvet-Protat S (1999). Economic evaluation of a prostate cancer screening program in France: a decision model. Crit Rev Oncol Hematol, 32, 167-73. DOI |
7 | Shteynshlyuger A, Andriole GL (2011). Cost-Effectiveness of prostate specific antigen screening in the United States: extrapolating from the European Study of screening for prostate cancer. J Urol, 185, 828-32. DOI |
8 | Imamura T, Yasunaga H (2008). Economic evaluation of prostate cancer screening with prostate-specific antigen. Int J Urol, 15, 285-8. DOI |
9 | Ahn J, Kim YH, Shin S, et al (2010). Research on Methodologies for Evidence Based Healthcare Decision Making Process in Korea. Seoul, Korea: National Evidence based Healthcare Collaborating Agency (NECA). |
10 | Hamashima C, Yoshida K (2000). Cost-effectiveness analysis of prostate cancer screening. Environ Health Prev Med, 5, 111-7. DOI |
11 | Holmberg H, Carlsson P, Lofman O, et al (1998). Economic evaluation of screening for prostate cancer: a randomized population based programme during a 10-year period in Sweden. Health Policy, 45, 133-47. DOI |
12 | Kim Y, Hwang JS, Ahn J, et al (2013). Utilities for prostate cancer by cancer stage and treatment step in Korea. Korean J Health Econ and Policy, 19, 1-20. |
13 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
14 | Jung KW, Won YJ, Kong HJ, et al (2013). Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat, 45, 1-14. DOI ScienceOn |
15 | Jung JW, Won YJ, Kong HK, et al (2013). Survival of Korean cancer patients by stage at diagnosis, 2006-2010: national cancer registry study. Cancer Res Treat, 45, 162-71. DOI ScienceOn |
16 | Ministry of Employment and Labor (2011). 2010 Survey Report on labor conditions by employment type. Seoul, Korea: Ministry of Employment and Labor. |
![]() |